{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["20"],"submitter":["Jones IA"],"pubmed_abstract":["<h4>Background</h4>Duloxetine is a Food and Drug Administration-approved selective norepinephrine reuptake inhibitor for treating depression, anxiety, fibromyalgia, and neuropathic and chronic musculoskeletal pain. This meta-analysis aims to evaluate the efficacy of duloxetine in reducing pain and postoperative opioid use following lower extremity total joint arthroplasty.<h4>Methods</h4>A literature search was performed, identifying randomized controlled trials investigating duloxetine for pain management after total hip and total knee arthroplasty. Data from the visual analog scale (VAS) for pain during movement and at rest were extracted for postoperative days (PODs) 1, 3, 7, and 14, as well as postoperative week 6 and postoperative month 3. Opioid use data were obtained at 24, 48 and 7"],"journal":["Arthroplasty today"],"pagination":["101097"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9957748"],"repository":["biostudies-literature"],"pubmed_title":["Duloxetine for Postoperative Pain Control Following Knee or Hip Replacement: A Systematic Review and Meta-Analysis."],"pmcid":["PMC9957748"],"pubmed_authors":["Jones IA","Heckmann ND","Christ AB","Murphy LS","Wang JC","Piple AS","Talehakimi A"],"additional_accession":[]},"is_claimable":false,"name":"Duloxetine for Postoperative Pain Control Following Knee or Hip Replacement: A Systematic Review and Meta-Analysis.","description":"<h4>Background</h4>Duloxetine is a Food and Drug Administration-approved selective norepinephrine reuptake inhibitor for treating depression, anxiety, fibromyalgia, and neuropathic and chronic musculoskeletal pain. This meta-analysis aims to evaluate the efficacy of duloxetine in reducing pain and postoperative opioid use following lower extremity total joint arthroplasty.<h4>Methods</h4>A literature search was performed, identifying randomized controlled trials investigating duloxetine for pain management after total hip and total knee arthroplasty. Data from the visual analog scale (VAS) for pain during movement and at rest were extracted for postoperative days (PODs) 1, 3, 7, and 14, as well as postoperative week 6 and postoperative month 3. Opioid use data were obtained at 24, 48 and 7","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Apr","modification":"2025-04-26T00:10:58.686Z","creation":"2025-04-06T09:34:27.676Z"},"accession":"S-EPMC9957748","cross_references":{"pubmed":["36852213"],"doi":["10.1016/j.artd.2023.101097"]}}